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Abstract
Background: Morbidity and mortality for women with chronic obstructive pulmonary disease (COPD) are
increasing, and little is known about gender differences in perception of COPD care.
Methods: Surveys were administered to a convenience sample of COPD patients to evaluate perceptions about
symptoms, barriers to care, and sources of information about COPD.
Results: Data on 295 female and 273 male participants were analyzed. With similar frequencies, women and men
reported dyspnea and rated their health as poor/very poor. Although more women than men reported annual
household income < $30,000, no significant gender differences in frequency of health insurance, physician visits,
or ever having had spirometry were detected. In adjusted models (1) women were more likely to report COPD
diagnostic delay (odds ratio [OR] 1.66, 95% confidence interval [CI] 1.13-2.45, p = 0.01), although anxiety (OR
1.83, 95% CI 1.10-3.06, p = 0.02) and history of exacerbations (OR 1.60, 95% CI 1.08-2.37, p = 0.01) were also
significant predictors, (2) female gender was associated with difficulty reaching one’s physician (OR 2.54, 95% CI
1.33-4.86, p = 0.004), as was prior history of exacerbations (OR 2.25, 95% CI 1.21-4.20, p = 0.01), and (3) female
gender (OR 2.15, 95% CI 1.10-4.21, p = 0.02) was the only significant predictor for finding time spent with their
physician as insufficient.
Conclusions: Significant gender-related differences in the perception of COPD healthcare delivery exist, re-
vealing an opportunity to better understand what influences these attitudes and to improve care for both men
and women.
Introduction
Chronic obstructive pulmonary disease (COPD) is thethird leading cause of death in the United States.1 The
burden of COPD among women continues to grow; the number
of women dying from COPD in the United States now exceeds
that of men.2 Information about gender differences in clinical
presentation and disease biology is accumulating, demonstrat-
ing that women tend to report more dyspnea and poorer quality
of life (QOL) for the same burden of disease and also may be
more susceptible to declines in lung function for the same levels
of tobacco exposure.3–6 Unfortunately, knowledge about gender
differences in coping with this chronic illness and interface with
the healthcare delivery system is more limited.
Data from female COPD participants in pulmonary re-
habilitation suggest that men and women use different types
of coping strategies to deal with the demands of their dis-
ease.7 As compared to men, women frequently use an
emotion-focused coping strategy, a response characterized
by such emotions as anxiety and depression. Anxiety and
depression have been reported with greater frequency
among women with COPD as compared to men.3 Emotional
health is a well-established determinant of the experience of
patients with the healthcare system8,9 and is associated with
healthcare services use.10 It is unknown, however, the extent
to which gender itself when adjusted for such factors as
depression and anxiety influences patient perceptions about
care delivery.
1University of Michigan Health System, Ann Arbor, Michigan.
2Novartis Pharmaceutical Corporation, East Hanover, New Jersey.
3National Emphysema/COPD Association, New York, New York.
4Innovative Health Solutions, Chestnut Hill, Massachusetts.
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Using data from a nationwide survey of patients with
COPD, commissioned by a patient organization, the COPD
Resource Network–National Emphysema/COPD Associa-
tion (NECA), we evaluated potential gender differences in
symptoms, barriers to care, and sources of information about
the disease and the effect of socioeconomic and emotional
factors on patient perceptions of care.
Materials and Methods
The current analyses are based on the results of a national
survey of patients with COPD conducted in 2007–2008.
Patient survey
The methods of the NECA-commissioned nationwide
surveys of COPD patients have been published previously.11
Briefly, a convenience sample of patients was assembled
based on COPD participants randomly selected from one of
several sources: (1) a national sample of households in which
at least one person reported a diagnosis of COPD based on a
database maintained by Integrated Business Services Inc.
(Lake Forest, IL), (2) participants of patient support groups
affiliated with the American Lung Association’s Better
Breathers Clubs or NECA, (3) COPD patients receiving oxy-
gen through a national provider (Apria Healthcare, Lake
Forest, CA), and (4) respondents to internet survey invitation
on COPD-related websites.
Participants were mailed a 7-page questionnaire, accom-
panied by an explanatory letter and a postage prepaid return
envelope. As incentive for participation, a summary of the
executive results of the surveys was offered. The total number
of completed surveys was 1,077 of 15,000 surveys sent (re-
sponse rate 7.2%). As the psychologic needs of asthma pa-
tients and the effect on gender-related patterns of healthcare
utilization have been studied and are better characterized
than in the COPD population,12,13 for purposes of the current
analyses, persons who reported a diagnosis of asthma or co-
existent asthma and COPD were excluded, leaving 568 pa-
tients with COPD for analysis. The questionnaire was
prepared with the help of COPD expert panels, including
physicians, patients, and representatives of COPD organiza-
tions. The items were considered to have face validity and to
be easy to understand. Questions included demographics;
comorbid conditions; perceived health and limitations for
daily activities; use of healthcare resources, including visits to
physicians and ancillary tests and therapies; and sources of
information about the disease.
Age was calculated based on reported year of birth; gender
and racial designation were selected by the respondent. An-
nual household income was selected from a list of seven op-
tions ranging from under $20,000 to over $150,000, with
responses recoded pooling the answers in two groups below
$30,000 and above $30,000. Frequency of symptoms was
based on the answer to the question: Has there been any
3-month period during the past year when you had the fol-
lowing symptoms every day or most days a week? Comorbid
conditions were self-reported based on a list of conditions
presented after the question: Which of the following condi-
tions, if any, have you ever been diagnosed with? The impact
of disease on a patient’s life was evaluated with multiple
choice questions, including: How would you describe your
overall health status at the moment?—with response options
from excellent to very poor—and: How severe are your cur-
rent COPD symptoms?—with response options in a Likert
scale from no symptoms to very severe, which were dichot-
omized for purposes of the current analysis. The Medical
Research Council (MRC) Dyspnea Index was used to describe
severity of breathlessness. The impact of COPD on work ca-
pacity was evaluated with the answers to the questions: Does
your lung condition keep you from working? Does your lung
condition limit the amount or type of work you can do?
The patient’s experience with the healthcare system was
evaluated through a series of questions about insurance sta-
tus, healthcare use, medical specialty of their provider, and
frequency of diagnostic tests. The frequency of visits to any
doctor and to a pulmonologist during the prior 12 months was
also evaluated. Compliance with oxygen and COPD-related
medications was self-reported. The patient had the opportu-
nity to describe if he or she has participated in a pulmonary
rehabilitation program and if to the best of his or her knowl-
edge, rehabilitation programs were available or if he or
she was not aware of this program. Sources of information
on COPD were selected from a list of options presented.
QOL was evaluated with the Living with COPD (LCOPD)
questionnaire.14 (Supplemental material available online at
www.liebertonline.com).
Statistical analysis
Data are presented as proportions and means, with stan-
dard deviations (SDs) as appropriate. Statistical comparisons
across gender for categorical data were made using chi-square
tests. Continuous data were compared with t tests. We tested
the independent effect of female gender on perceptions of
healthcare using logistic regression models. Other variables
included and tested in the model were selected based on the
patient factors included in the Theoretical Model of Acces to
Healthcare.15 The variables included in the analyses include
factors related to emotional health (reported anxiety and de-
pression), severity of disease (history of exacerbations and use
of oxygen), socioeconomic status (based on annual income),
and age. All p values were two-tailed, with a p value < 0.05
considered statistically significant. Analyses were performed
using SAS 9.2 (SAS Institute, Cary, NC).
Results
Demographics
The characteristics of the 568 patients with COPD who re-
sponded to the survey, their symptoms, comorbid conditions,
and data on COPD care are shown in Table 1. Women sur-
veyed are younger than men and also reported their symp-
toms started at a younger age and were diagnosed at a
younger age. The annual household income for women was
significantly lower than that of men, with 59.9% of women
reporting annual household income < $30,000 vs. 44.2% of
men, p < 0.001.
Symptoms, comorbid conditions, and disease impact
Symptoms and comorbidities by gender are also reported
in Table 1. Cough and phlegm in the past 3 months were
reported with less frequency by women than by men. The
prevalence of comorbid conditions among this sample dem-
onstrated that arthritis, hypertension, diabetes, and stroke
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were reported with similar frequency by both women and
men, but heart disease was reported with less frequency by
women. More women than men, however, reported obesity,
osteoporosis, anxiety, and depression. A similar proportion of
women and men had at least one hospital admission sec-
ondary to COPD during the prior year and at least one visit to
the emergency room secondary to a COPD exacerbation. In
general, women reported that COPD had a similar impact on
their daily lives as it had to men. Severe breathlessness, ac-
cording to the MRC Dyspnea Questionnaire, was described
with similar frequency by women and men. Women and men
reported with similar frequency that their disease limited the
amount of time they could work, as well as kept them from
working.
COPD management
Almost all respondents recalled spirometry testing at some
point during the course of their disease, and almost two thirds
of participants had been prescribed oxygen. Oxygen com-
pliance between genders was similar. Although more
women than men reported having received steroids for an
Table 1. Demographic and Clinical Characteristics of Respondents to 2007 National Emphysema/COPD
Association Survey with a Diagnosis of Chronic Obstructive Pulmonary Disease
Characteristic
Males with
COPD n = 273
Females with
COPD n = 295 p value
Demographics
Mean (SD) age at time of survey (years) 73.1 (8.3) 70.1 (10.2) < 0.001
Mean (SD) age at first symptoms (years) 62.4 (12.0) 59.3 (14.3) 0.009
Mean (SD) age at diagnosis (years) 62.0 (10.1) 59.4 (12.7) 0.009
Annual income < $30,000 (%) 44.2 59.9 < 0.001
Self-described as white (%) 96.0 96.6 0.84
Education beyond high school (%) 63.2 52.2 0.01
Symptom frequency (%)
Shortness of breath 85.0 85.1 0.97
Cough 56.8 51.2 0.18
Phlegm 61.9 47.1 < 0.001
Any nocturnal symptom 29.3 30.5 0.75
Comorbid diseases (%)
Heart disease 32.0 21.4 0.004
Anxiety 12.9 24.4 < 0.001
Depression 15.8 24.1 0.01
Obesity 9.9 17.0 0.01
Osteoporosis 7.0 36.3 < 0.001
Arthritis 33.5 40.3 0.09
Diabetes 21.0 17.0 0.22
Hypertension 45.2 46.8 0.71
Migraine 1.5 5.4 0.01
Sleep disorder 16.2 16.6 0.88
Self-rated health and limitations (%)
Self-rated poor or very poor health 22.0 18.6 0.31
Severe or very severe symptoms 40.7 33.1 0.07
Severe dyspnea (MRC dyspnea score 3–4) 26.5 24.6 0.60
Symptoms keep me from work 30.4 25.8 0.21
Symptoms limit amount of work 51.7 44.1 0.07
Mean score LCOPD questionnaire 9.9 (6.1) 9.7 (6.0) 0.81
Exacerbations last year (%)
At least one with hospital admission 28.6 26.1 0.51
At least one with emergency room visit 24.5 26.4 0.60
COPD management and medications (%)
Ever had spirometry 97.4 96.6 0.56
Oxygen use 62.8 61.8 0.80
Continuous oral steroids 18.4 14.1 0.15
Steroids during exacerbations 25.3 34.4 0.02
Use oxygen as much as prescribed 78.4 83.8 0.20
Very compliant with medications 85.1 84.7 0.89
Very persistent with medications 95.5 94.1 0.45
Has ever stopped COPD medications 23.8 25.3 0.68
Prefers dry-powdered inhalers 62.3 54.6 0.06
Prefers metered dose inhalers 57.5 54.2 0.48
Believes medications are effective 91.2 90.6 0.46
COPD, chronic obstructive pulmonary disease; LCOPD, Living with COPD; MRC, Medical Research Council; SD, standard deviation.
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Table 2. Healthcare Experience, Perceptions on Healthcare, and Expectations of Respondents
to the 2007 National Emphysema/COPD Association Survey with a Diagnosis of Chronic
Obstructive Pulmonary Disease
Males with
COPD n = 273
Females with
COPD n = 295 p value
Provider managing COPD (%)
Pulmonologist 54.3 53.8 0.84
Primary care provider/internist 43.2 41.1 0.59
Other providers involved (%)
Cardiologist 46.0 29.2 < 0.001
Otolaryngologist 9.6 7.2 0.32
Endocrinologist 6.5 6.1 0.85
Psychiatrist 4.6 4.0 0.72
Total number of providers, mean (SD) 1.8 (1.1) 1.6 (1.2) 0.03
Insurance (%)
Medicare 77.3 71.4 0.11
Through employer/work 35.2 28.6 0.09
Lacks insurance 1.5 1.4 0.92
Medicaid 6.2 9.9 0.11
Visits to physicians prior 12 months
Any physician, mean (SD) 7.7 (6.3) 6.8 (5.2) 0.06
Pulmonologist, mean (SD) 2.8 (3.0) 2.9 (3.6) 0.72
Experience with rehabilitation (%)
Have participated in rehabilitation 48.0 40.5 0.07
Not aware of rehabilitation programs 25.3 31.3 0.11
Pulmonary rehabilitation is not available 13.0 18.7 0.07
Uncertain rehabilitation is helpful 17.6 13.3 0.15
Does not believe rehabilitation works 3.7 2.7 0.51
Perception about healthcare (%)
Believes diagnosis was delayed 26.7 36.3 0.02
Doctor is difficult to reach 5.8 14.2 < 0.001
Doctor sympathetic to condition 90.4 83.4 0.01
Feels treated poorly as smoker 10.5 13.2 0.34
Not enough time with my physician 5.7 12.4 0.006
Very satisfied with my physician 58.2 63.0 0.24
Insurance is a barrier for at least one aspect of care 16.8 24.5 0.03
Insurance is a barrier for obtaining prescription medication 2.6 5.4 0.83
Insurance is a barrier for rehabilitation 7.0 5.8 0.56
Insurance is a barrier for antibiotics 1.1 3.4 0.06
Insurance barrier for medications to control symptoms 6.2 9.9 0.11
Knowledge about COPD
Aware of guidelines 44.7 46.3 0.70
Very well/adequately informed 89 82.7 0.03
Source of education/information (%)
Physician 89.8 81.3 0.004
Respiratory therapist 48.7 42.2 0.11
Nurse 36.6 29.6 0.07
Books, magazines 33.7 34.4 0.87
Other patients 12.5 19.1 0.03
Television or cable 12.8 11.6 0.64
Patient organizations 12.1 14.3 0.44
Online support groups 13.6 20.4 0.03
Other internet resources 22.7 25.9 0.38
Important activities to promote (%)
Access to treatment 64.6 77.0 0.001
Development of new therapies 55.2 77.7 < 0.001
Clinical research 44.5 60.7 < 0.001
Educational materials 33.7 47.5 < 0.001
Public awareness 33.9 56.3 < 0.001
Screening 40.9 61.8 < 0.001
Pulmonary rehabilitation 56.3 67.2 0.006
Research funding 50.5 60.3 0.02
Education of physicians 48.3 65.1 < 0.001
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exacerbation during the last 12 months, no difference in con-
tinuous oral steroid use was reported.
Healthcare and pulmonary rehabilitation experience
Data on the respondents’ healthcare experience, participation
in rehabilitation, and disease education are summarized in
Table 2. For women and men surveyed, the healthcare provider
managing his or her COPD was more frequently a pulmonol-
ogist, and internists or primary care physicians came in second.
When asked about other physicians involved in their care,
women had contact with cardiologists with lower frequency,
but no gender differences in the frequency of visiting a psychi-
atrist were seen. For both women and men, the most frequent
health insurer was Medicare, and almost one third of subjects
reported having insurance through their employer. Lack of in-
surance coverage was similar between men and women. Wo-
men and men reported pulmonary rehabilitation program
participation with similar frequency. A similar, but significant,
proportion of women and men were unaware of the existence of
rehabilitation programs, and lack of access to a program in their
area was also similar between women and men.
Sources of information on COPD
For women, sources of information about COPD differed
significantly from those of men. Women reported less receipt
of education from their physician but were more likely than
men to obtain information from other patients and online
support groups. However, slightly fewer women than men
believed they were very well or adequately informed about
their health condition (Table 2).
Differences and factors related to perceptions
of healthcare
Women reported with greater frequency the belief that they
experienced a delay in their diagnosis, believed their physicians
were more difficult to reach when they needed care, and felt that
the time spent with their doctor was insufficient. However, overall
satisfaction with their physician’s disease management was sim-
ilar for men and women. Although the frequency and distribution
of health insurance was no different between women and men,
with the proportion of uninsured women and men being similar
in this cohort, more women than men described their insurance as
a barrier for at least one component of the healthcare process. No
significant difference was seen in the percent of women vs. men
who believed that their insurance was a barrier to accessing an-
tibiotics or symptom-relieving medications.
In order to understand the impact of potential confounders,
multivariate models were constructed to determine if gender
differences in perceptions of care still existed when adjusted
for factors associated with income, disease severity (exacer-
bation history and oxygen use), and history of anxiety and
depression. In adjusted models, women were still more likely
to report a diagnostic delay (odds ratio [OR] 1.66, 95% con-
fidence interval [CI] 1.13-2.45, p = 0.01), although anxiety (OR
1.83, 95% CI 1.10-3.06, p = 0.02) and history of prior exacer-
bation in the last year (OR 1.60, 95% CI 1.08-2.37, p = 0.01)
were also significant predictors. In adjusted models, female
gender was also still associated with finding one’s physician
difficult to reach (OR 2.54, 95% CI 1.33-4.86, p = 0.004), as was
prior history of exacerbations (OR 2.25, 95% CI 1.21-4.20,
p = 0.01), whereas other predictors were nonsignificant. In
adjusted models predicting whether time spent with one’s
doctor was insufficient, female gender (OR 2.15, 95% CI 1.10-
4.21, p = 0.02) was the only significant predictor. Interestingly,
in modeling the belief that insurance is a barrier to at least one
area of one’s care, female gender becomes nonsignificant; low
income, however, is the only significant predictor (OR 1.77,
95% CI 1.12-2.77, p = 0.01) (Table 3).
Discussion
With the growing burden of COPD among women, un-
derstanding gender differences in disease presentation and
access to care becomes critically important. Our results extend
previous findings that women with COPD report lower fre-
quency of cough and sputum production4 and experience
greater frequency of depression and anxiety,16–18, osteopo-
rosis,19 and obesity.20 At the same time, our data provide new
findings regarding gender differences in patient perceptions
and expectations of the healthcare system. Despite reporting
similar access to healthcare insurance, physicians, and pul-
monary rehabilitation, more women than men reported in-
surance as a barrier to at least one aspect of their care. More
women also believed they had experienced a diagnostic delay
of their COPD, reported difficulties in reaching their physi-
cian, and believed the time with their treating physician to be
insufficient. As the potential sources of disease education for
patients with COPD are rapidly expanding, women obtained
information about their disease from online support groups,
and fewer obtained disease information from their physician
as compared to men.
Some of the most interesting findings of our study relate to
perceptions that women with COPD have about their inter-
actions with the healthcare system. More women reported
Table 3. Multivariate Analysis of Factors Related to Perceptions on Healthcare Experience
of Respondents to the 2007 National Emphysema/COPD Association Survey
with a diagnosis of Chronic Obstructive Pulmonary Disease
Female gendera Anxiety Exacerbations Low income
Diagnosis was delayed 1.66 (1.13-2.45), 0.01 1.83 (1.10-3.06), 0.02 1.60 (1.08-2.37), 0.01 NS
Doctor difficult to reach 2.54 (1.33-4.86), 0.004 NS 2.25 (1.20-4.20), 0.01 NS
Insufficient time with doctor 2.15 (1.10-4.21), 0.02 NS NS NS
Insurance is a barrier NS NS NS 1.76 (1.12-2.77), 0.01
Multivariate models additionally adjusted for depression and use of oxygen.
aFor all predictors, odds ratio (95% confidence interval), p-value.
NS, nonsignificant.
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that their insurance was a barrier to receiving at least one
aspect of their care. However, no discernible difference in the
percentage of patients insured or frequency of visits to phy-
sicians was detected. As the annual household income for
women in this survey was less than that for men, it is possible
that the impact of out-of-pocket expenses could lead to greater
barriers for healthcare access for women. Supportive of this
possibility, in multivariate models adjusted for annual in-
come, income itself but not gender was the only significant
predictor of perceiving insurance as a barrier to care.
Women also reported greater difficulty reaching their
doctor. In adjusted models, female gender and history of prior
exacerbations were significant predictors of the perception
that one’s physician is difficult to reach. Clincial trials de-
signed to evaluate different COPD interventions suggest that
exacerbations may occur with higher frequency in wom-
en21,22; therefore it is possible that women are expressing
more frustration as they have greater need to be seen quickly
for exacerbations, for which the healthcare system may not be
well adapted.
In unadjusted and adjusted models, female gender was the
only explanatory variable associated with the perception that
the time spent with the physician was insufficient. Fewer
women also believed their doctor was sympathetic to their
condition. Why women describe a poorer experience with
these aspects of the healthcare system is unclear. One prior
study of COPD patients revealed no significant gender dif-
ferences in patient satisfaction with their care.23 This prior
study, however, was an international survey, which may
contribute to a difference in findings. It is possible that the
actual amount of time each physician spends with women is
less than it is for men or that women have greater need for
time with their physicians. Another possible explanation for
this finding may be gender discordance between male phy-
sicians and female patients. Studies in a variety of medical
settings have shown that physician-patient disconcordance
on a number of social characteristics, including gender, is
associated with a less positive perception of care.24,25
Our data demonstrate that women perceive a greater delay
in diagnosis, even when they were on average younger in
age compared to male participants when they received their
diagnosis. Female gender was still associated with the per-
ception of diagnostic delay when adjusted for relevant con-
founders, such as socioeconomic status, disease severity, and
history of anxiety and depression. There is growing evidence
on gender differences in quality and extent of care with other
chronic conditions,26–28 but specific data on COPD are lim-
ited. Self-reported delay in care for women with diabetes and
cardiovascular disease has been published, with differences
maintained in both insured and uninsured patients.28 In the
respiratory community, there has been suspicion that women
with COPD could be underdiagnosed, based on results of two
studies demonstrating that given similar clinical scenarios,
physicians are more likely to make a diagnosis of COPD in
male vs. female subjects.29,30 Our data provide, for the first
time, evidence that women with COPD actually perceive a
delay in diagnosis. Whether these data represent a difference
in the propensity to self-identify a need of care or an actual
gender-related difficulty in obtaining the care is unclear and
will need to be evaluated in further prospective evaluations.
Women surveyed also reported higher frequency of anxi-
ety, depression, osteoporosis, and obesity than men but lower
frequency of heart disease. It is unknown to what extent these
data are influenced by physician bias or differences in the
healthcare received. Interestingly, although 32.0% of men
and 21.4% of women in this study reported a history of heart
disease, 46.0% of men but only 29.2% of women had a car-
diologist involved in their care. It has been reported that
women are less likely to receive referrals to specialists.31 With
respect to other aspects of their care, male and female par-
ticipants surveyed here received their COPD-related care
from pulmonologists, internists, and other primary care
practitioners with similar frequency, and the mean number of
additional physicians involved in the patient’s care was
higher for women than for men in this survey. At a minimum,
these data highlight the need for physicians to be aware that
cardiovascular disease is common in both men and women
with COPD and must be considered in diagnostic and ther-
apeutic decision making.
Disease education is critically important, as a relationship
between the level of a patient’s health literacy and health
outcomes in chronic diseases has been documented.32 Edu-
cation and information are even more critical for management
of chronic and multidimensional diseases, such as COPD,
where it has been shown that basic therapeutic interventions,
such as the use of inhalers, can be a challenge for patients.33
We inquired about sources for medical information for COPD
patients and found that women were less likely than men to
obtain knowledge about their disease from their physician
and more likely to rely on other patients and online support
groups. These data underscore the importance of good com-
munication skills for healthcare providers, particularly for
female patients, and suggest that women need to engage with
other patients as part of their coping strategy for living with a
chronic illness. Data from other chronic diseases suggest that
women are more likely to report the use of coping strategies
and find these strategies effective.34 Although almost one
quarter of the respondents used other internet resources for
information, the overall proportion of respondents using the
internet for disease education is low compared with the
numbers in other surveys.35 This is likely due to the elderly
nature of the surveyed population, as those seeking medical
information on the internet tend to be younger.35 As access to
the internet increases, particularly for elderly patients with
limited mobility, another opportunity for education and
outreach will be available that may be particularly valuable to
women with COPD and should be encouraged.
One limitation of this study is that it relies on self-response,
with no validation of responses on use of medical services,
comorbid conditions, and barriers to use of medical services,
including delay in healthcare. However, similar methodology
and questionnaire content have been used in previous surveys
targeting a similar population.11,36 It is difficult to know with
certainty if systematic biases exist between men and women
with respect to survey data participation and response, but
current evidence does not support this suspicion.37 Another
potential limitation of these data is the lack of information on
pulmonary function or disease severity descriptors. An ad-
ditional limitation is that this is a convenience sample with a
low response rate (7.2%) and may not be representative of the
general patient population. The high self-reported frequency
of oxygen use suggests that the severity of disease in this
cohort is high, and results may not be generalizable to the less
severe COPD patients.
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Conclusions
In this analysis of a national survey of COPD patients, signifi-
cant differences between men and women were found, especially
in access to and receipt of care and health information. Despite
apparently similar access to healthcare insurance, physician visits,
and pulmonary rehabilitation, women were more likely than men
to report inadequacies in the quality of the care received for their
COPD, including perception of COPD diagnostic delay, insuffi-
cient time spent with their doctor, and difficulty reaching their
doctor, even after adjustment for income, disease severity, and
indicators of mental health. This information highlights the need
for further research to identify the factors influencing these atti-
tudes and coping strategies and design interventions to improve
care for both men and women with COPD.
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